Skip to main content
Top
Published in: Ophthalmology and Therapy 5/2023

Open Access 27-06-2023 | Artificial Intelligence | ORIGINAL RESEARCH

Patients’ Perception of Robot-Driven Technology in the Management of Retinal Diseases

Authors: Kah Long Aw, Sirindhra Suepiantham, Aryelly Rodriguez, Alison Bruce, Shyamanga Borooah, Peter Cackett

Published in: Ophthalmology and Therapy | Issue 5/2023

Login to get access

Abstract

Introduction

There is increasing application of robots and other artificial intelligence-driven technologies in the management of retinal disease. These technologies have the potential to meet increasing demands for retinal diseases. However, there is currently a lack of understanding of patients’ attitudes towards use of robots in ophthalmology. This study investigates patients’ attitudes towards robot-led management of retinal disease.

Methods

Paper questionnaires were distributed to 177 patients attending intravitreal treatment (IVT) at the Princess Alexandra Eye Pavilion between 1 October 2022 and 31 January 2023. The questionnaire collected information on age, sex, diagnosis and postcode. In the questionnaire, patients responded to questions about their attitudes towards robot-led diagnosis, treatment decisions and IVT injections. Responses were collected using a 5-category Likert scale which was analysed using ordinal logistic regression with adjustments for age, sex and deprivation status.

Results

Those from affluent socioeconomic backgrounds were significantly (p < 0.001) more accepting of robots diagnosing and deciding on treatment, although the total number of patients who were accepting was only 26 (14.7%). Furthermore, there was an increased proportion of patients who would accept robots if the robot made fewer mistakes than doctors, if the robot reduced waiting or appointment time and if the robot was able to communicate well and have empathy; the same association with socioeconomic background remains (p < 0.001). Lastly, 116 patients (65.5%) would not be happy if IVT injections were performed by a robot; this was more likely the case if the patient was female (p = 0.04) or from a more deprived socioeconomic background (p < 0.001).

Conclusion

Attitudes towards robot involvement in diagnosis and management of retinal disease are significantly associated with socioeconomic backgrounds and sex. Additional studies are required to further investigate these determinants of robot receptiveness to ensure acceptance and compliance with treatment with these new technologies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schmidt-Erfurth U, Sadeghipour A, Gerendas BS, Waldstein SM, Bogunović H. Artificial intelligence in retina. Prog Retin Eye Res. 2018;67:1–29.CrossRefPubMed Schmidt-Erfurth U, Sadeghipour A, Gerendas BS, Waldstein SM, Bogunović H. Artificial intelligence in retina. Prog Retin Eye Res. 2018;67:1–29.CrossRefPubMed
2.
4.
go back to reference Shahriari MH, Sabbaghi H, Asadi F, Hosseini A, Khorrami Z. Artificial intelligence in screening, diagnosis, and classification of diabetic macular edema: a systematic review. Surv Ophthalmol. 2023;68(1):42–53.CrossRefPubMed Shahriari MH, Sabbaghi H, Asadi F, Hosseini A, Khorrami Z. Artificial intelligence in screening, diagnosis, and classification of diabetic macular edema: a systematic review. Surv Ophthalmol. 2023;68(1):42–53.CrossRefPubMed
5.
go back to reference Lanzetta P, Loewenstein A. Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases. Graefes Arch Clin Exp Ophthalmol. 2017;255(7):1259–73. CrossRefPubMedPubMedCentral Lanzetta P, Loewenstein A. Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases. Graefes Arch Clin Exp Ophthalmol. 2017;255(7):1259–73. CrossRefPubMedPubMedCentral
6.
go back to reference Chopra R, Preston GC, Keenan TD, et al. Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye. 2021;36(7):1373–8.CrossRefPubMedPubMedCentral Chopra R, Preston GC, Keenan TD, et al. Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye. 2021;36(7):1373–8.CrossRefPubMedPubMedCentral
7.
go back to reference Okada M, Mitchell P, Finger RP, et al. Nonadherence or nonpersistence to intravitreal injection therapy for neovascular age-related macular degeneration. Ophthalmology. 2021;128(2):234–47.CrossRefPubMed Okada M, Mitchell P, Finger RP, et al. Nonadherence or nonpersistence to intravitreal injection therapy for neovascular age-related macular degeneration. Ophthalmology. 2021;128(2):234–47.CrossRefPubMed
8.
go back to reference Polat O, İnan S, Özcan S, et al. Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in patients with age-related macular degeneration. Türk Oftalmoloji Dergisi. 2017;47(4):205–10.CrossRef Polat O, İnan S, Özcan S, et al. Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in patients with age-related macular degeneration. Türk Oftalmoloji Dergisi. 2017;47(4):205–10.CrossRef
10.
go back to reference Jung S. Does education affect risk aversion? Evidence from the British Education Reform. Appl Econ. 2015;47(28):2924–38.CrossRef Jung S. Does education affect risk aversion? Evidence from the British Education Reform. Appl Econ. 2015;47(28):2924–38.CrossRef
12.
go back to reference Yang R, Wibowo S. User trust in artificial intelligence: a comprehensive conceptual framework. Electron Mark. 2022;32(4):2053–77.CrossRef Yang R, Wibowo S. User trust in artificial intelligence: a comprehensive conceptual framework. Electron Mark. 2022;32(4):2053–77.CrossRef
13.
go back to reference Siau K, Wang W. Building trust in artificial intelligence, machine learning, and robotics. Cutter Bus Technol J. 2018;31:47–53. Siau K, Wang W. Building trust in artificial intelligence, machine learning, and robotics. Cutter Bus Technol J. 2018;31:47–53.
14.
go back to reference Felten E, Raj M, Seamans R. Occupational, industry, and geographic exposure to artificial intelligence: a novel dataset and its potential uses. Strateg Manag J. 2021;42(12):2195–217.CrossRef Felten E, Raj M, Seamans R. Occupational, industry, and geographic exposure to artificial intelligence: a novel dataset and its potential uses. Strateg Manag J. 2021;42(12):2195–217.CrossRef
16.
go back to reference Saxby E, Cheng K, O’Connell N, Sanders R, Agarwal PK. Is there an association of socioeconomic deprivation with acute primary angle closure? Eye. 2021;36(6):1246–52.CrossRefPubMedPubMedCentral Saxby E, Cheng K, O’Connell N, Sanders R, Agarwal PK. Is there an association of socioeconomic deprivation with acute primary angle closure? Eye. 2021;36(6):1246–52.CrossRefPubMedPubMedCentral
17.
go back to reference Mundy KM, Nichols E, Lindsey J. Socioeconomic disparities in cataract prevalence, characteristics, and management. Semin Ophthalmol. 2016;31(4):358–63.CrossRefPubMed Mundy KM, Nichols E, Lindsey J. Socioeconomic disparities in cataract prevalence, characteristics, and management. Semin Ophthalmol. 2016;31(4):358–63.CrossRefPubMed
18.
go back to reference Pinto dos Santos D, Giese D, Brodehl S, et al. Medical students’ attitude towards artificial intelligence: a multicentre survey. Eur Radiol. 2018;29(4):1640–6.CrossRefPubMed Pinto dos Santos D, Giese D, Brodehl S, et al. Medical students’ attitude towards artificial intelligence: a multicentre survey. Eur Radiol. 2018;29(4):1640–6.CrossRefPubMed
19.
go back to reference Hengstler M, Enkel E, Duelli S. Applied Artificial intelligence and trust—the case of autonomous vehicles and medical assistance devices. Technol Forecast Soc Chang. 2016;105:105–20.CrossRef Hengstler M, Enkel E, Duelli S. Applied Artificial intelligence and trust—the case of autonomous vehicles and medical assistance devices. Technol Forecast Soc Chang. 2016;105:105–20.CrossRef
Metadata
Title
Patients’ Perception of Robot-Driven Technology in the Management of Retinal Diseases
Authors
Kah Long Aw
Sirindhra Suepiantham
Aryelly Rodriguez
Alison Bruce
Shyamanga Borooah
Peter Cackett
Publication date
27-06-2023
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy / Issue 5/2023
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-023-00762-5

Other articles of this Issue 5/2023

Ophthalmology and Therapy 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare